Ravi A Madan M.D.
@Dr_RaviMadan
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR) & #immunotherapy. Views are my own & do not represent the National Cancer Institute
ID:746355556458323968
24-06-2016 14:53:26
3,1K Tweets
2,8K Followers
306 Following
Follow People
Wow!
Leading the way in #prostatecancer #imaging and beyond. Improving lives for men with prostate cancer around the world 🌎
Baris Turkbey MD Peter Choyke CCR Molec Imaging NCI Center for Cancer Research NCI Center for Cancer Research National Cancer Institute
💫🌟Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The #EMBARK Trial
📚 Authors: David Einstein, Meredith Regan, ScD, Julia S. Stevens, David F. @McDermott, Ravi A Madan M.D..
OncoAlert
🔍 Key findings
🔬 PSA detects micrometastatic
“You don’t need to know how to do everything. You need a vision and a sustainable team that continues to pay it forward.” Felix Feng
My heart is filled with love for Felix Feng celebrating the translational research he pioneered, clinical trials he shepherded, trainees he mentored. He is generational. A legacy. Toni Choueiri, MD Josh Lang Paul Nguyen UC San Francisco UC San Diego Health Moores Cancer Center
Brilliant paper from Harvard University
David Einstein
▶️ Critical analysis of EMBARK study...
ascopubs.org/doi/pdf/10.120…
Please donate and I can send you a poster of Felix Feng and Josh Lang exchanging jackets ! #FengSymposium
Out now in Journal of Clinical Oncology , Meredith Regan, ScD Ravi A Madan M.D. Julia Stevens, Uromigos David McDermott, and I ask how to approach tx goals & endpoints in biochemically recurrent prostate cancer in the EMBARK era:
· Is metastasis-free survival (MFS) meaningful?
· Is extending MFS “worth it”?
Excited to be awarded a 2024 CCR Health Disparities Travel Award to participate in the #AACRdisp24 meeting!
Congrats to all recipients and many thanks to NCI CCR Med Onc Service and NCI Center for Cancer Research !
🔔Education Opportunity for Patients with #ProstateCancer & Their Families
📆 5/17/24 8amEST (virtual)
Here from experts discussing
✴️ Diet/Lifestyle 🚴♂️
✴️ AI 🤖
✴️ Biochemical Recurrence 📈
✴️ Genetics 🧬
✴️ Survivorship ☺️
Register for FREE! ✍🏽
Link: shorturl.at/ehjx8
This free virtual seminar, happening this Friday, includes the presentation 'Living Well as a Prostate Cancer Survivor' by Dr. Alicia Morgans Alicia Morgans, MD, MPH and more from our Brigham and Women's Hospital colleagues as well
Ravi A Madan M.D. Ana Aparicio Michael Hofman Thomas Hope prof. Stefano Fanti Ken Herrmann Dana Rathkopf silke gillessen aurelius omlin Advanced Prostate Cancer Consensus Conference Michael Morris Journal of Clinical Oncology Agree! Smart imaging can be used smarter. PSMA PET is prognostic and we should use it as a tool to help define treatment failure as well as progression. We just need to develop the methods and evidence.....
📢I am happy to share our new publication 'Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN' oncotarget.com/article/28583/…
👍Congratulations to Kevin Ma, Stephanie Harmon and our Team🎉 #ArtificialIntelligence #GenerativeAI #ProstateCancer #AI
Paper Drop from the #ShafiLab ⬇️
Center for Prostate Disease Research Karen Knudsen, MBA PhD NCI CCR GU Malignancies PCF Science Gregory Chesnut Adam Sharp EllisLab_ Allen Su Uniformed Services University biorxiv.org/content/10.110…
Happy #NursesWeek ! It’s the perfect time to thank the amazing nurses in our communities for all that they do. Special shout out to the nurses at National Cancer Institute and NIH Clinical Center. Your dedication and hard work make a difference for patients every day and help #EndCancerAsWeKnowIt .